Pulmozyme

Part of speech: noun

Definitions

1. A medicinal enzyme preparation used primarily to break down mucus in the lungs, facilitating easier breathing for patients with cystic fibrosis or similar respiratory conditions
2. A therapeutic agent characterized by its ability to enzymatically degrade pulmonary secretions, aiding in the clearance of mucus to improve lung function in certain chronic diseases
3. A biologically derived treatment designed to reduce the viscosity of sputum in the respiratory system by enzymatic action, thereby supporting respiratory health in affected individuals

Etymology: Pulmozyme is a brand name, not a word that grew organically in English. It was coined by the pharmaceutical company Genentech, which developed the drug dornase alfa, a recombinant form of the human enzyme deoxyribonuclease I (DNase I). The name combines "pulmo-," from Latin "pulmo," meaning "lung," with "-zyme," a common pharmaceutical suffix derived from Greek "zumē," meaning "leaven" or "ferment," and used in English for enzymes since the early 1900s. The "zyme" element traces back to the 19th-century German chemist Wilhelm Kühne, who coined "enzyme" in 1877 from Greek roots meaning "in leaven." The drug itself was approved by the US Food and Drug Administration in 1993 and became a mainstay of cystic fibrosis treatment. Its enzyme works by cutting the long strands of DNA released by dying white blood cells, which thicken the mucus in the airways. Because the name is a modern construction from classical roots, it follows the same pattern as many medical terms coined in the twentieth century, rather than having an ancient or folk origin.